Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycosaminoglycans | 4 | 2023 | 611 | 1.190 |
Why?
|
| Heparitin Sulfate | 9 | 2024 | 224 | 0.890 |
Why?
|
| Sepsis | 5 | 2023 | 2602 | 0.720 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2021 | 112 | 0.720 |
Why?
|
| Glycocalyx | 5 | 2023 | 98 | 0.700 |
Why?
|
| Pulmonary Artery | 3 | 2019 | 1949 | 0.650 |
Why?
|
| Sulfotransferases | 1 | 2019 | 150 | 0.630 |
Why?
|
| Aneurysm | 1 | 2019 | 338 | 0.530 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 704 | 0.400 |
Why?
|
| Lung | 5 | 2023 | 10090 | 0.360 |
Why?
|
| Pneumonia, Bacterial | 2 | 2023 | 319 | 0.350 |
Why?
|
| Chondroitin Sulfates | 3 | 2023 | 174 | 0.320 |
Why?
|
| Hemodynamics | 2 | 2016 | 4202 | 0.300 |
Why?
|
| Pneumonia | 1 | 2019 | 2162 | 0.290 |
Why?
|
| Endothelial Cells | 1 | 2019 | 3586 | 0.270 |
Why?
|
| Lung Injury | 2 | 2020 | 435 | 0.230 |
Why?
|
| Decorin | 1 | 2023 | 38 | 0.230 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10494 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 18388 | 0.220 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2023 | 39 | 0.210 |
Why?
|
| Proteoglycans | 2 | 2023 | 807 | 0.200 |
Why?
|
| Silver Staining | 1 | 2021 | 63 | 0.190 |
Why?
|
| Oligosaccharides | 2 | 2023 | 406 | 0.190 |
Why?
|
| Pulmonary Atelectasis | 1 | 2022 | 160 | 0.180 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 835 | 0.160 |
Why?
|
| Acute Lung Injury | 1 | 2023 | 378 | 0.160 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1734 | 0.150 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 8201 | 0.150 |
Why?
|
| Pulmonary Alveoli | 1 | 2020 | 666 | 0.140 |
Why?
|
| Hippocampus | 2 | 2019 | 3783 | 0.130 |
Why?
|
| Animals | 15 | 2024 | 169418 | 0.130 |
Why?
|
| Mice | 11 | 2024 | 82045 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 1412 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2019 | 2216 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 1605 | 0.110 |
Why?
|
| Rats | 3 | 2019 | 23839 | 0.100 |
Why?
|
| Memory Disorders | 1 | 2019 | 1204 | 0.100 |
Why?
|
| Heparin | 1 | 2019 | 1636 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2022 | 1540 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2024 | 7895 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 22365 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 4425 | 0.070 |
Why?
|
| Staphylococcus aureus | 2 | 2024 | 1461 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 607 | 0.060 |
Why?
|
| Cathelicidins | 1 | 2023 | 81 | 0.060 |
Why?
|
| Angiopoietin-2 | 1 | 2024 | 173 | 0.050 |
Why?
|
| Trypsin | 1 | 2024 | 494 | 0.050 |
Why?
|
| Disaccharides | 1 | 2023 | 170 | 0.050 |
Why?
|
| Syndecan-1 | 1 | 2023 | 163 | 0.050 |
Why?
|
| Cytotoxins | 1 | 2022 | 154 | 0.050 |
Why?
|
| Ion Exchange | 1 | 2021 | 16 | 0.050 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2023 | 353 | 0.050 |
Why?
|
| Male | 8 | 2024 | 364781 | 0.050 |
Why?
|
| Desiccation | 1 | 2021 | 78 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2024 | 618 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2016 | 9382 | 0.050 |
Why?
|
| Solutions | 1 | 2021 | 411 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2023 | 596 | 0.040 |
Why?
|
| Biofilms | 1 | 2024 | 634 | 0.040 |
Why?
|
| Bleomycin | 1 | 2020 | 495 | 0.040 |
Why?
|
| Syndecans | 1 | 2018 | 75 | 0.040 |
Why?
|
| Virulence | 1 | 2022 | 1303 | 0.040 |
Why?
|
| Glucuronidase | 1 | 2020 | 205 | 0.040 |
Why?
|
| Humans | 10 | 2024 | 768451 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 394 | 0.040 |
Why?
|
| Long-Term Potentiation | 1 | 2019 | 290 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2020 | 722 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 1697 | 0.030 |
Why?
|
| Capillary Permeability | 1 | 2018 | 773 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1348 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2022 | 1738 | 0.030 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 56 | 0.030 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 935 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1660 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 4138 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 3861 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 2723 | 0.020 |
Why?
|
| Female | 4 | 2024 | 396943 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2024 | 54914 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 991 | 0.020 |
Why?
|
| Sex Factors | 1 | 2022 | 10647 | 0.020 |
Why?
|
| Pyrroles | 1 | 2013 | 1127 | 0.020 |
Why?
|
| Cell Line | 1 | 2020 | 15609 | 0.020 |
Why?
|
| Child | 2 | 2024 | 80863 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1834 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 15460 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 7471 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 20231 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2013 | 2062 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10865 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 36497 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2024 | 42623 | 0.010 |
Why?
|
| Cognition | 1 | 2019 | 7066 | 0.010 |
Why?
|
| Prognosis | 1 | 2022 | 30028 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2020 | 23638 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 89168 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81834 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74915 | 0.010 |
Why?
|
Concepts
(98)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_